My first Magazine Global Cancer Biomarkers Market Size, Shares 2021 | Page 2



Drug discovery
Development and drug formulation
By Type:



Protein Biomarkers
Genetic Biomarkers
Other Biomarkers
By Profiling Technologies:






Omics technologies
 Genomics
 Proteomics
 Metabolomics
 Transcriptomics
 Pharmacogenomics
Imaging technologies
Immunoassays
Cytogenetics
Bioinformatics
IVD multivariate index assays
Customized report URL: http://www.marketdataforecast.com/market-reports/global-
cancer-biomarkers-market-2239/customize-report
Based on geography, the market is analysed under various regions namely, North America,
Latin America, Europe, Asia-Pacific and Middle-East & Africa. The Asia-Pacific market is
poised to record the highest growth rate in the forecast period due to the supporting
government funding for cancer biomarker research, increasing prevalence of cancer, rising
demand for advanced healthcare facilities in developing economies such as India and China,
growing number of clinical trials, and rising focus of international players in emerging
markets.





North America Cancer Biomarkers Market
Europe Cancer Biomarkers Market
Asia-Pacific Cancer Biomarkers Market
Latin America Cancer Biomarkers Market
Middle East and Africa Cancer Biomarkers Market
Some of the major players in this market are Abbott Laboratories, Agendia Bv, Biocurex Inc,
Biomerieux S.A., Biomoda Inc, Astellas Pharma Us Inc, Correlogic Systems Inc, Beckman
Coulter Inc, Becton, Dickinson And Company, Clarient Inc, Diadexus Inc, Ambrilia Biopharma,
Affymetrix Inc and Aureon Laboratories Inc.
The Cancer Biomarkers Market study offers the following deliverables: